Wednesday, April 8, 2026

Korean Politics Meets Markets This Week: High-Profile Trials, Powell’s Signal, and a Semiconductor Supercycle

Key discussions in South Korea include judicial reforms, upcoming court verdicts, and significant earnings reports from Samsung and SK Hynix.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Tag: broadcasting errors

No posts to display

Top News

- Our Sponsors Ad -

Follow us